Canada Life’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,765
| Closed | -$10K | – | 2483 |
|
|
2022
Q1 | $10K | Hold |
4,765
| – | – | ﹤0.01% | 2437 |
|
|
2021
Q4 | $13K | Hold |
4,765
| – | – | ﹤0.01% | 2429 |
|
|
2021
Q3 | $21K | Hold |
4,765
| – | – | ﹤0.01% | 2432 |
|
|
2021
Q2 | $28K | Hold |
4,765
| – | – | ﹤0.01% | 2422 |
|
|
2021
Q1 | $33K | Hold |
4,765
| – | – | ﹤0.01% | 2420 |
|
|
2020
Q4 | $23K | Hold |
4,765
| – | – | ﹤0.01% | 2516 |
|
|
2020
Q3 | $28K | Hold |
4,765
| – | – | ﹤0.01% | 2351 |
|
|
2020
Q2 | $32K | Buy |
+4,765
| New | +$36.1K | ﹤0.01% | 2385 |
|
|
2019
Q3 | – | Sell |
-7,034
| Closed | -$104K | – | 2491 |
|
|
2019
Q2 | $104K | Hold |
7,034
| – | – | ﹤0.01% | 2217 |
|
|
2019
Q1 | $174K | Hold |
7,034
| – | – | ﹤0.01% | 1912 |
|
|
2018
Q4 | $122K | Buy |
7,034
+2,489
| +55% | +$50.9K | ﹤0.01% | 2083 |
|
|
2018
Q3 | $134K | Hold |
4,545
| – | – | ﹤0.01% | 2101 |
|
|
2018
Q2 | $207K | Hold |
4,545
| – | – | ﹤0.01% | 1973 |
|
|
2018
Q1 | $240K | Sell |
4,545
-1,859
| -29% | -$108K | ﹤0.01% | 1914 |
|
|
2017
Q4 | $435K | Buy |
6,404
+1,366
| +27% | +$95.5K | ﹤0.01% | 1771 |
|
|
2017
Q3 | $403K | Buy |
5,038
+745
| +17% | +$59.1K | ﹤0.01% | 1775 |
|
|
2017
Q2 | $401K | Hold |
4,293
| – | – | ﹤0.01% | 1756 |
|
|
2017
Q1 | $273K | Buy |
4,293
+1,500
| +54% | +$91.2K | ﹤0.01% | 1843 |
|
|
2016
Q4 | $125K | Hold |
2,793
| – | – | ﹤0.01% | 2051 |
|
|
2016
Q3 | $101K | Hold |
2,793
| – | – | ﹤0.01% | 2132 |
|
|
2016
Q2 | $38K | Hold |
2,793
| – | – | ﹤0.01% | 2369 |
|
|
2016
Q1 | $54K | Hold |
2,793
| – | – | ﹤0.01% | 2095 |
|
|
2015
Q4 | $98K | Hold |
2,793
| – | – | ﹤0.01% | 1781 |
|
|
2015
Q3 | $258K | Hold |
2,793
| – | – | ﹤0.01% | 1116 |
|
|
2015
Q2 | $245K | Hold |
2,793
| – | – | ﹤0.01% | 1273 |
|
|
2015
Q1 | $207K | Hold |
2,793
| – | – | ﹤0.01% | 1331 |
|
|
2014
Q4 | $156K | Hold |
2,793
| – | – | ﹤0.01% | 1448 |
|
|
2014
Q3 | $127K | Hold |
2,793
| – | – | ﹤0.01% | 1498 |
|
|
2014
Q2 | $115K | Buy |
2,793
+2,000
| +252% | +$103K | ﹤0.01% | 1482 |
|
|
2014
Q1 | $55K | Hold |
793
| – | – | ﹤0.01% | 1739 |
|
|
2013
Q4 | $48K | Buy |
+793
| New | +$43.1K | ﹤0.01% | 1818 |
|
Other funds holding CLVS
PAI
QF
E
PA
Canada Life's CLVS Position: Q2 2022 in Review
Canada Life sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 4,765 shares — an estimated $10K sold.
Canada Life first reported a position in CLVS in Q4 2013 and held it in 31 quarters. The position peaked at $435K in Q4 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.
- Canada Life reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
- Canada Life sold 4,765 Clovis Oncology, Inc. shares in Q2 2022, an estimated $10K.
- Canada Life first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 31 quarters.
- Canada Life's Clovis Oncology, Inc. position peaked at $435K in Q4 2017.
- 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.
Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.